Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 8, Issue:3, March, 2019

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(3): 528-535
DOI: https://doi.org/10.20546/ijcmas.2019.803.064


Multi Drug Resistant Staphylococcus haemolyticus An Emerging Nosocomial Pathogen in Neonatal Sepsis at Tertiary Care Centre, Thanjavur
Eunice Swarna Jacob and Hari Prasanth*
Department of Microbiology, Govt Thanjavur Medical College, Thanjavur, India
*Corresponding author
Abstract:

Staphylococcus haemolyticus is part of the human normal skin microflora and is also found in nonhuman primates. This organism has been documented as a cause of primary and nosocomial bacteremia in clinical health care settings. Though CONS is ruled out as a contaminant, the emergence of multidrug-resistant isolates to glycopeptides, methicillin, fluoroquinolones, macrolides, lincosamides, streptogramin B and linezolid results in treatment failure in primary bacteremia. Transmission of resistant clones among Staphylococcus species necessitates the correct identification of Staphylococcus species for prompt treatment and identification plays a vital role in the prevention of nosocomial spread among healthcare workers. In this retrospective study we identified Staphylococcus haemolyticus from blood cultures sent to microbiology department from neonatal intensive care unit during the period from January to December 2018 by antimicrobial susceptibility testing and tested for various resistance patterns by CLSI standards. This study signifies the importance of identification of Staphylococcus haemolyticus species among CONS in neonatal sepsis and it's various resistance pattern to increase the antibiotic stewardship in clinical healthcare settings.


Keywords: Staphylococcus haemolyticus, Nosocomial Pathogen, Neonatal sepsis

Download this article as Download

How to cite this article:

Eunice Swarna Jacob and Hari Prasanth. 2019. Multi Drug Resistant Staphylococcus haemolyticus An Emerging Nosocomial Pathogen in Neonatal Sepsis at Tertiary Care Centre, Thanjavur.Int.J.Curr.Microbiol.App.Sci. 8(3): 528-535. doi: https://doi.org/10.20546/ijcmas.2019.803.064
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations